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Abstract: The reliable measurement of quality of life (QoL) presents a challenge in individuals 
with alcohol-related brain damage. This study investigated vagally mediated heart rate variability 
(vmHRV) as a physiological predictor of QoL. Self- and proxy ratings of QoL and dysexecutive 
symptoms were collected once, while vmHRV was repeatedly assessed over a 3-week period 
at weekly intervals in a sample of nine alcohol-related brain damaged patients. We provide 
robustness checks, bootstrapped correlations with confidence intervals, and standard errors for 
mean scores. We observed low to very low heart rate variability scores in our patients in com-
parison to norm values found in healthy populations. Proxy ratings of the QoL scale “subjective 
physical and mental performance” and everyday executive dysfunctions were strongly related 
to vmHRV. Better proxy-rated QoL and fewer dysexecutive symptoms were observed in those 
patients with higher vmHRV. Overall, patients showed low parasympathetic activation favoring 
the occurrence of dysfunctional emotion regulation strategies.
Keywords: heart rate variability, emotion regulation, alcohol-related brain damage, quality of life
Introduction
Healthy individuals without cognitive impairment can adapt flexibly to challenges in 
their environment, while individuals with cognitive impairment may struggle with 
behavioral, emotional, and cognitive adaptability. Success in these processes contrib-
utes to the person’s general well-being and enhances the individual’s experience of 
quality of life (QoL). When evaluating QoL in those without cognitive impairment, 
clinicians and researchers acknowledge that individuals are the experts of their own 
QoL.1,2 Patients’ perceptions of their QoL are, therefore, assessed using self-report 
measures of QoL, including subjective well-being and/or objective functioning.3 
Assessing QoL in patients with severe cognitive deficits using such self-report mea-
sures, however, poses a challenge due to the nature of their impairment. In patients 
with alcohol-related brain damage (ARBD), for example, self-report measures of QoL 
may yield results with questionable reliability and are, therefore, often replaced in 
clinical practice by expert ratings, that is, proxy measures. Such proxy ratings may 
provide valuable information of QoL, especially with respect to concrete and observ-
able aspects of QoL.1 In using self- and proxy ratings as a source of information, the 
general phenomenon of judgmental inaccuracies between raters needs to be addressed. 
Three perspectives on truth in terms of judgmental accuracy have been proposed: 
consensus, correspondence, and pragmatic accuracy.4 Accuracy as consensus refers 
to the consistency of ratings from at least two  different judges. In a recent study 
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important outcome measures of medical and psychosocial 
interventions. Improving the reliability of QoL measures 
in this patient sample, therefore, seems mandatory for both 
research and clinical practice.
A possible solution may be to refer to the correspondence 
theory of truth,4 defined as the correspondence between a 
judgment and a more objective criterion. The present study 
aims at addressing this issue. We investigated vagally medi-
ated heart rate variability (vmHRV), an objectively measur-
able physiological parameter, as an indicator of emotion 
regulation capacity. vmHRV has recently been shown to be 
related to QoL in individuals with compromised intellec-
tual capacities,12 making vmHRV a promising candidate to 
index QoL as a result of an individual’s capacity to regulate 
emotions.
Offline analysis of variability of interbeat intervals in a 
resting condition allows for the extraction of parameters of 
prefrontally modulated vagal activation. Prefrontally modu-
lated and vmHRV under resting conditions is considered a 
marker for regulated emotional responding13 and a correlate 
of prefrontal cortical functions.14 Recent research has shown 
associations between vmHRV and self-reported measures 
of emotion regulation and QoL in intellectually impaired 
and visually challenged individuals.12 This interpretation 
with relation to QoL is based on extensive research relat-
ing vmHRV to crucial predictors of mental well-being 
such as successful emotion regulation capacity,13,15,16 better 
self-regulatory skills,17 and better top-down modulation of 
emotional responses due to higher prefrontal cortical inhibi-
tory capacity.14,18,19 A lack of prefrontal inhibitory control 
over subcortical brain regions that are involved in emotional 
processing gives rise to emotional dysregulation such as 
emotional instability and perseverative thinking, which are 
in turn related to impaired life satisfaction and lower QoL.20
Low vmHRV is associated with a number of negative 
health outcomes related to emotional dysregulation such as 
depression,19,21 anxiety,21 and stress.22 Lower vmHRV has 
further been related to a range of subclinical risk factors for 
emotional instability such as less efficient safety learning and 
extinction of previously learnt stress responses,23 increased 
sensitivity to and dysfunctional cognitive processing of pain-
related stimuli,24 suboptimal decision-making in risky and 
emotionally challenging social situations,25,26 and emotional 
instability in everyday life of healthy individuals.15
As vmHRV is typically derived from heart rate recordings 
under resting conditions for a short period of 5 minutes,27 
it is not affected by confounding influences of partici-
pants’ cooperation, their motivation, deception, and social 
 investigating QoL in ARBDs, we investigated the consen-
sus of QoL evaluations using self- and proxy ratings, the 
latter provided by health care professionals who were well 
acquainted with the patients. We observed a significant lack 
of concordance between both types of QoL ratings, suggest-
ing very low inter-rater consistency.5 Interestingly, patients 
judged their QoL similar to a large healthy normative 
sample, while health care professionals assessed patients’ 
QoL significantly lower. On the one hand, this finding con-
tradicts previous results in the sense that individuals with 
alcohol use disorder generally score lower than the general 
population on a number of QoL-related indices.6 On the 
other hand, the observed gap between self-report and proxy 
ratings have been reported in previous studies.1,7 Neverthe-
less, a review by Sneeuw et al8 show fair to moderate levels 
of concordance between patient and physician ratings in 
general, with physicians’ ratings of patients’ level of health 
and functioning tending to be lower than those provided 
by the patients themselves. The authors conclude from this 
review that proxy ratings provided by health care providers 
on several aspects of patients’ QoL are reasonably accurate.8 
However, if patient and proxy ratings are at odds, it is gener-
ally accepted that patient ratings should be retained.1
It should be noted, however, that studies investigating 
patient/proxy agreement in QoL include a wide variety of 
clinical populations. The strength of the reported concor-
dance between patients’ and proxy QoL ratings may probably 
be a function of severity of patients’ cognitive impairments. 
Due to the severity of cognitive impairment experienced 
by a proportion of individuals with ARBD, patients are no 
longer able to live independently and, therefore, require 
long-term, 24-hour care, including basic functions such as 
personal hygiene.9 In addition, most ARBD patients have a 
history of failed psychiatric rehabilitation and unsuccessful 
social reintegration, demonstrate a range of cognitive and 
affective impairments10 and considerable levels of anosog-
nosia.5 Given their advanced stage of cognitive impairment, 
patients with ARBD are, therefore, no longer able to lead an 
independent life. The level of cognitive/affective dysfunc-
tion and anosognosia, together with the previously observed 
repetitive failure of intense therapeutic and rehabilitative 
measures in these patients prior to their admission casts 
doubt on the reliability – and hence validity – of self-reported 
QoL in patients with ARBD.8,11 The applicability of the con-
sensus concept of truth4 in evaluating QoL in these patient 
populations may thus be compromised. This is critical, as in 
addition to complex clinical tests assessing physical health 
status per se, ratings on QoL and well-being constitute 
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the occurrence of dysexecutive symptoms in everyday life, 
using a correlative within-subject design. Hence, we aim to 
investigate vmHRVs role as a potential biomarker for QoL 
and emotion regulation in clinical settings.
Methods
Sample
The initial sample consisted of 18 detoxified patients with 
chronic alcohol abuse living in a specialized ward providing 
24-hour care and support. Of these, four patients withdrew 
their participation over the course of the investigation (ie, 
more than one of three HRV assessments missing), and one 
patient was excluded from the study because of deteriorat-
ing health status (benign tumor diagnosis). The remaining 
sample consisted of 13 patients with a mean age of 58.3 years 
(standard deviation [SD] =6.9; range =45.7–66.5). Given the 
widespread nature of neurotoxic effects of chronic alcohol 
abuse,5,10 these patients are characterized by significant levels 
of cognitive and functional impairments requiring 24-hour 
care and support in a specialized nursing ward. All patients 
had a history of chronic, heavy alcohol use, repeated relapse, 
and unsuccessful psychiatric rehabilitation prior to entering 
the present ward. Due to equipment failures (eg, storage 
failure, signal loss) an additional four patients were excluded 
from analysis, resulting in a final sample of nine patients. 
Table 1 summarizes sample characteristics, including 
sociodemographic data, medical comorbidities, and current 
pharmacological treatment. Due to unique characteristics of 
this particular sample, an age-matched healthy control group 
was deemed neither necessary nor helpful, as the unambigu-
ous interpretation of group differences in terms of diagnosis 
would not have been possible due to differences at multiple 
levels (eg, pharmacotherapy, psychiatric and physical comor-
bidities, and general lifestyles).
Ethical considerations
The present study’s aims, design, procedure, and publication of 
anonymous data were reviewed and approved by two indepen-
dent ethical research boards (Ethics Review Panel, University 
of Luxembourg [Reference ERP13-021 ALCOQUOL LB/vg]; 
National Ethical Research Board of Luxembourg [Approval 
201310/01]) prior to recruitment and data collection. In 
addition, the treating physician (ie, an external psychiatrist 
independent of the present research institutions and without 
potential conflict of interest) was asked to provide written 
informed consent on the method, the goal of the study, and 
the anonymous publication of the results for each participant 
independently. Furthermore, the general practitioner and legal 
 desirability, which makes it a candidate for an objective 
biomarker of QoL and well-being in cognitively impaired 
individuals. Importantly, vmHRV measures obtained at rest 
are commonly interpreted as trait, but can be affected by state 
components28 that might confound trait-based interpretations 
(such as trait-QoL). With single measurements, which are 
common in the vast majority of research on heart rate vari-
ability (HRV) and health, the trait component has recently 
been estimated to be only 49%,28 which gives rise to the 
assumption that the statistical power of analyses involving 
measures of HRV assessment is generally overestimated. 
In the present research, we thus implemented repeated (up 
to three) measurements and calculated the mean, thereby 
maximizing the trait-component of our measure in order 
to compensate for unintended confounding factors by the 
challenging characteristics of our sample.
Vagally mediated HRV has mostly been used in basic 
research. In the present study, we aimed to investigate the 
practicability of vmHRV under the complex conditions found 
in a normally operating institution. The clinical environment 
entails practical and methodological limitations that are 
characteristic for clinical institutions caring for vulnerable 
and chronic, multimorbid patients. All these characteristics 
could pose serious limitations to the use of vmHRV as a 
diagnostic tool in clinical practice. ARBD rarely occurs 
alone, that is, these patients typically present with a wide 
range of comorbidities. In the present research, we aimed 
to investigate a naturalistic sample of patients with ARBD, 
including the entire range of comorbidities, pharmacologi-
cal and other treatments, extent of neurological damage, and 
sociodemographic variables, to best reflect everyday clinical 
practice. The present sample, therefore, combines a range of 
patient characteristics that are commonly considered “exclu-
sion criteria” and are not recommended for basic research. 
Nevertheless, these characteristics are common and constitute 
a threshold between basic science with high internal but 
limited external validity and practical use. We are aware that 
a demonstrated relationship between QoL and vmHRV does 
not allow for conclusions on direct causal relationships. To 
demonstrate causality, intervention studies using longitudinal 
designs are required.
In summary, we investigate the practicability of vmHRV 
measurement and interpretation for the assessment of well-
being and QoL in a small naturalistic clinical sample of 
patients with severe ARBD. More precisely, we conceptualize 
vmHRV as an objective and trait-related measure of emo-
tion regulation capacity and examine its associations with 
1) self-reported and 2) proxy-reported QoL/well-being and 
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guardians of each patient were informed about the study in 
general and asked to raise objections if applicable. Prior to indi-
vidual data collection, the health care professional in charge 
informed the patient about the following procedure including 
the possibility to withdraw from participation at any time and 
without any further consequences. (The informed consent 
process differed from the Declaration of Helsinki of 1975, as 
revised in 2000. This is especially the case for §27, §28, §29, 
and §30 of the Declaration of Helsinki. By Luxembourg law, 
legally authorized representatives are not competent in provid-
ing written informed consent for the participant to participate 
in a study [Luxembourg Law of August 11, 1982; see external 
link {only available in French language}: http://www.legilux.
public.lu/leg/a/archives/1982/0072/a072.pdf].)
Materials and procedure
Heart rate recording
Measurement of heart rate was performed individually at 
rest in a separate room with the patient sitting in a comfort-
able armchair using the heart rate monitor Polar RS800CX 
(Polar, Kempele, Finland).29,30 Patients were well accustomed 
to the room as it is located in the ward and is regularly used 
for relaxation purposes. On the ward, the three health care 
professionals who were in charge of heart rate measurements 
were well acquainted with the patients and experienced in 
conducting relaxation sessions with them. For the purpose 
of the present study, relaxation sessions were individually 
performed with one health care professional present in the 
same room. Patients were accustomed to these kinds of 
relaxation sessions as they are regularly performed either 
in a group or individual format. The measurement trial was 
part of a regularly performed 30 minutes relaxation session, 
with the patient performing relaxation exercises during the 
first 15 minutes of the session under the supervision and 
instruction of the health care professional in charge. For the 
following 10 minutes, patients were instructed to lean back 
in the chair, to relax, and to avoid any movements. A 5-min-
ute period of this relaxation phase was used to record heart 
rate to guarantee maximum relaxation. The last 5 minutes 
of the 30 minutes session were used to exit the relaxation 
Table 1 Sociodemographics, medical information, and relevant pharmacological treatment in each patient
Characteristics ARBD1 ARBD2 ARBD3 ARBD4 ARBD5 ARBD6 ARBD7 ARBD8 ARBD9
Sociodemographics
Age at time of study (years) 46.9 57.4 55.4 45.7 49.6 64.7 60.1 61.3 59.6
Time living in present ward, at time of study 
(months)
3 19 107 4 101 19 106 28 20
Marital status Divorced Married Single Divorced Divorced Divorced Divorced Divorced Divorced
Work status Invalidity – Invalidity Invalidity Invalidity Retired – Invalidity Retired
Alcohol abuse >10 years X – X X X X X X X
History of alcoholism in family X – – X – – – X X
Medical information
ICD10 diagnosis, primary F10.6 F10.6 F10.6 F10.6 F10.6 F10.6 F10.6 F10.6 F10.6
ICD10 diagnosis, secondary K86.0 F32 F32 G62.1 I62.1 F32 E11 F32 F32
CIRS-G
Organ-specific categories endorsed 4 4 3 4 3 6 4 6 5
Organ categories with moderate disabilities 2 2 1 2 2 3 3 4 2
Overall severity index 2.0 2.0 2.0 2.0 2.3 1.8 2.3 2.0 2.2
Atrophies on MRI
Mammillary bodies – X X X – X X X X
Cerebellum – – – X – – – – X
Cortex – X X X – X X – –
Pharmacological treatment
Beta-blocker – – – – – – – X X
BZD and related substances – X – X – X – X –
Neuroleptic – – – X X* – X X –
Antidepressant X X X – X X* – X –
Thyroid extract – – – – – X – – –
Notes: CIRS-G.44 Organ-specific categories rated on a Likert-type scale from 0 (no problem) to 4 (extremely severe, organ failure): heart, vascular, hematopoietic, 
respiratory, eyes/ears/nose/throat/larynx, upper gastrointestinal tract, lower gastrointestinal tract, liver, renal, genitourinary, musculoskeletal-integument, neurological, 
endocrine-metabolic-breast, and psychiatric illness. A moderate disability is defined by requiring a first-line therapy, overall severity index represents the number of organ-
specific categories endorsed/total score (unreported here). *If required.
Abbreviations: ARBD, alcohol-related brain damage; BZD, benzodiazepines; CIRS-G, Cumulative Illness Rating Scale for Geriatrics; ICD, International Classification of 
Diseases; MRI, magnetic resonance imaging; “–”, data not available or condition does not apply; “X”, condition applies.
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training. Heart rate was recorded three times per participant 
in identical settings as recommended by Bertsch et al,28 with 
an interval of 1 week between measurements. Each heart rate 
recording was standardized according to the same protocol, 
with assessments per participant corresponding to the same 
period of the day (eg, always in the morning) and with the 
same health care professional as the preceding assessment.
Self- and proxy ratings
Self-ratings were collected with the help of a certified clinical 
psychologist who interviewed each patient on the respective 
items and who was acquainted with them. We implemented 
this approach to rule out a possible lack of comprehension 
given patients’ cognitive deficiencies described in Steinmetz 
and Federspiel.10 Proxy ratings differ from self-ratings only 
by health care professionals being instructed to base their 
ratings on their personal experiences with and the impres-
sions of the target patient.
QoL ratings
QoL was assessed using the QoL-profile for chronically ill 
patients.31 This self-rating instrument is a 40-item generic 
measure using a 5-point Likert scale to assess the degree of 
accordance on six different QoL domains: “subjective physi-
cal and mental performance” (scale 1), “ability to have plea-
sure and relaxation” (scale 2), “presence of positive mood” 
(scale 3), “absence of negative mood” (scale 4), “ability to 
relate/contact/approach” (scale 5), and “sense of affiliation” 
(scale 6). The QoL-profile instrument and data are described 
in a previous publication,5 as they were collected in January 
2013 and thus ~10 to 12 months prior to the present study’s 
data collection period (November 2013–January 2014).
Cognitive deficit ratings
Cognitive impairments were assessed using the Dysexecu-
tive Questionnaire (DEX), a 20-item self- and expert-rating 
questionnaire taken from the Behavioral Assessment of the 
Dysexecutive Syndrome battery.32 Ratings are made on a 
5-point Likert scale (0–4, ranging from “never” to “very 
often”) with a maximum total score of 80. The DEX assesses 
the frequency with which observable everyday manifestations 
of executive dysfunction occur. The DEX was assessed in the 
same period as vmHRV measurements (data collection period 
ranging from November 2013 to January 2014).
Data analysis
Interbeat intervals were retrieved via the software Polar Pro 
Trainer 5.0 (Polar). All data were screened for measurement 
errors, these were deleted and substituted by means of cubic 
spline interpolation, and statistical time and frequency domain 
measures of vmHRV were obtained. Data processing and sta-
tistical analysis followed Task Force recommendations27 and 
was carried out using ARTiiFACT software,33 which is based 
on an error detection algorithm defining individual threshold 
criteria for erroneously detected interbeat intervals developed 
by Berntson et al.34 The root mean square successive differ-
ence (rMSSD) was calculated as a time domain measure. 
The high frequency component (HF-HRV, 0.15–0.40 Hz) was 
obtained via fast-Fourier transformation (interpolation rate 4 
Hz, window width 256 seconds, window overlap 50%). Time 
and frequency domain measures are based on very different 
statistical approaches, but both are considered to be reliable 
indicators of vagal activation14,27,28 and are usually highly cor-
related.35–38 To maximize the proportion of the trait component 
and to minimize state-dependent effects on vmHRV,15,28 statis-
tical analyses were limited to those participants from whom 
data could be obtained from at least two measurement ses-
sions. Reported 95% confidence intervals (CIs) and standard 
errors (SEs) were estimated using bootstrapping with 1,000 
replications. Given the challenging small sample size, signifi-
cance tests for normalization are not considered sufficiently 
reliable, therefore both parametric and nonparametric testing 
procedures were conducted as a conservative and transparent 
approach to investigate robustness of the findings.
Results
Table 2 provides descriptive statistics of vmHRV parameters. 
Compared to available norms in healthy adults,29 mean levels 
of both vmHRV parameters (rMSSD and HF-HRV) in the 
present patient sample were considerably lower. rMSSD 
ranged from 3.9 (SD =0.5) to 17.5 (SD =5.9), with an over-
all mean of 10.7 (SD =4.5) (bootstrapped: SE
Mean
 =1.4; CI 
[7.9,13.6]), whereas Nunan et al39 observed an overall mean 
value of 42 (SD =15) ranging between 19 and 75. For the 
frequency domain measure HF-HRV, we observed a similar 
pattern in the present sample ranging from 3.9 (SD =2.1) to 
163.6 (SD =70.8) and an overall mean of 45.5 (SD =29.2) 
(bootstrapped: SE
Mean
=13.8; CI [22.5,75.2]), whereas norm 
values reported by Nunan et al39 are considerably higher, 
ranging from 82 to 3,630 and a computed cross study overall 
mean of 657 (SD =777).
Self- and proxy ratings
Results of the QoL measures on a similar but larger patient 
sample are presented and discussed in Steinmetz et al.5 
Although these preliminary findings from the present small 
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sample have limited generalizability, results support these 
previous findings with QoL ratings from patients being 
higher on four of the six dimensions than those of the proxies 
(Table 2). Similarly, proxies rate the frequency of everyday 
cognitive impairments to be somewhat higher than self-raters 
suggesting the occurrence of anosognosia in patients. Again, 
these findings are in line with previous results,5 whereas con-
firmation of the findings is required in other larger samples 
before firm conclusions on the occurrence of anosognosia 
in patients with ARBD can be drawn.
Relationships of vmHRV with QoL and 
DEX
Bootstrapped correlation analyses between rMSSD and 
self- and proxy-rated QoL revealed an interesting pattern of 
relationships. Linear relationships that are discussed were 
investigated using Pearson’s correlation coefficient r. When 
using Spearman’s rank order correlation coefficient (rho), the 
pattern of correlations was similar to Pearson’s r, except for 
the QoL-profile scale 4 (absence of negative mood) (details 
are presented in Table 3).
Table 2 QoL and dysexecutive failures as rated by patients and health carers, and heart rate variability results
ARBD1 ARBD2 ARBD3 ARBD4 ARBD5 ARBD6 ARBD7 ARBD8 ARBD9 P
S P S P S P S P S P S P S P S P S P
QoL-profile
Subjective 
physical 
and mental 
performance 
(scale 1)
– – 2.0 0.9 3.2 1.7 – – 2.4 2.2 2.2 1.6 2.6 2.4 1.8 1.6 3.2 2.4 0.014
Ability to have 
pleasure and 
relaxation 
(scale 2)
– – 2.5 1.0 3.0 2.2 – – 3.0 2.6 2.7 2.4 3.1 2.9 2.4 1.7 2.4 1.6 0.006
Presence of 
positive mood 
(scale 3)
– – 1.8 0.1 3.0 1.5 – – 2.8 1.8 1.6 1.7 3.2 2.4 1.8 0.7 2.2 1.3 0.004
Absence of 
negative mood 
(scale 4)
– – 2.4 0.8 2.1 2.9 – – 4.0 3.3 3.6 2.9 3.6 3.4 2.7 2.2 3.1 2.2 0.098
Ability to 
relate/contact/
approach 
(scale 5)
– – 1.7 0.6 3.8 1.8 – – 2.8 1.6 2.3 1.8 1.7 2.7 2.5 1.2 2.7 1.7 0.059
Sense of 
affiliation 
(scale 6)
– – 3.0 1.2 3.4 2.2 – – 3.4 2.6 3.4 2.5 3.4 3.1 2.2 2.5 1.4 1.4 0.050
DEX
Total score 16 18 – – 22 35 7 41 28 31 – – 8 29 – – – – 0.071
Vagally mediated heart rate variability
Number of 
measurements
3 2 3 3 3 3 2 2 3 n/a
Parameters, 
mean (SD)
Interbeat 
interval
826.4 (50.3) 643.8 (23.8) 683.6 (32.1) 612.3 (22.6) 673.5 (80.3) 794.7 (135.4) 794.1 (21.3) 730.2 (91.5) 729.9 (183.2) n/a
Heart rate 72.8 (4.5) 93.3 (3.4) 87.9 (4.0) 98.1 (3.6) 89.9 (10.2) 77.1 (14.4) 75.4 (2.0) 82.8 (10.4) 85.3 (18.8) n/a
rMSSD 17.5 (5.9) 5.1 (2.5) 8.1 (2.2) 3.9 (0.5) 11.3 (4.2) 11.1 (1.9) 15.4 (1.5) 11.4 (6.6) 12.6 (15.4) n/a
HF-HRV 163.6 (70.8) 8.6 (6.5) 23.8 (10.0) 3.9 (2.1) 53.5 (40.4) 37.1 (20.9) 56.9 (32.1) 26.3 (23.4) 35.5 (56.6) n/a
Notes: QoL-profile for chronically ill patients.31 For scale names, please refer to the text. Higher scores indicate a more positive QoL rating. DEX taken from the BADS.32 
Higher DEX scores indicate higher ratings on the occurrence of everyday cognitive failures. HF-HRV (0.15–0.40 Hz) expressed in absolute values P of scale mean differences 
(dependent t-tests, two-tailed) between self- and proxy ratings. Number of measurements, number of vagally mediated heart rate variability assessments available and taken 
into account per person in the context of the present study.
Abbreviations: ARBD, alcohol-related brain damage; BADS, Behavioral Assessment of the Dysexecutive Syndrome; DEX, Dysexecutive Questionnaire; HF-HRV, high 
frequency component; n/a, not available; P, proxy rating from acquainted health care professionals; QoL-profile, quality of life profile; rMSSD, root mean square of successive 
difference; S, self-rating; SD, standard deviation; “–”, data not available or not provided.
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Small- to moderate-sized correlations (total mean 
r=|0.30|) were observed between rMSSD and self-rated 
QoL (with one exception, scale 4 in Table 3), whereas 
correlations between rMSSD and proxy-rated QoL were 
considerably higher (total mean r=|0.75|) (Table 3). When 
inspecting corresponding SEs and 95% CIs of these cor-
relations, only proxy-rated QoL-profile scale “subjective 
physical and mental performance” (scale 1) remained valid 
with a CI ranging from 0.47 to 0.99 (Table 3). The remaining 
correlations between self- and proxy-rated QoL with rMSSD 
had large SEs and hence large 95% CIs and thus warrant 
no further interpretation. Considering correlations between 
self-rated everyday cognitive failures (DEX total score), a 
weak relationship was observed with rMSSD (r=−0.08, rho 
=0.20), whereas a nearly perfect negative relationship with 
rMSSD was observed for the proxy rating (r=−0.94), with 
95% CIs ranging from −1.00 to −0.84 (Table 3). Robustness 
of correlations was checked using the robustfit algorithm 
implemented in MATLAB® software (The MathWorks, Inc., 
Natick, MA, USA). The robustfit function computes the dif-
ference between ordinary least square regressions and robust 
regressions, yielding nonsignificant β differences between 
least square and robust regressions (−1.96<Z>+1.96), with 
one exception (self-rated QoL scale 5 with rMSSD, Figure 1). 
Nonsignificant β differences indicate that linear relationships 
are relatively robust with no or only minor influences from 
extreme scores (ie, outliers) on one or the other variable.
Discussion
The purpose of the present study was to investigate the use-
fulness of vmHRV as a correlate of well-being and QoL in a 
clinical sample of severely deteriorated ARBD individuals. 
We related the patient’s emotion regulation capacity with 
self- and proxy-rated QoL/well-being. Additionally, we 
investigated possible relationships of vmHRV with self- and 
proxy-reported executive failures.
In general, we observed low to very low HRV scores 
compared to healthy adults.39 Although preliminary, this 
suggests a remarkably low tonic parasympathetic activa-
tion that might indicate diminished prefrontal inhibitory 
control in these patients. Limited inhibitory control may 
favor the occurrence of dysfunctional psychological adap-
tation to internal or external input and hence, emotional 
dysregulation in daily life,15 reduced general self-regulatory 
abilities,17,19 and overall reduced QoL.12 Previously, low 
vmHRV has been associated with numerous negative health 
outcomes related to emotional dysregulation. Our sample is 
characterized by a relatively high prevalence of  psychiatric T
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Figure 1 Comparison of ordinary least square regressions and robust regressions for self- and proxy ratings on the six QoL-profile scales (A–L) and the occurrence of 
everyday executive dysfunctions (M and N).
Notes: QoL-profile for chronically ill patients.31 For scale names, please refer to the text. Higher scores indicate a more positive QoL rating. DEX taken from the BADS.32 
Higher DEX scores indicate higher ratings on the occurrence of everyday cognitive dysfunctions. The red line represents the ordinary least squares regression line. The green 
line represents the robust regression computed by the robustfit algorithm implemented in MATLAB® software (The MathWorks, Inc., Natick, MA, USA).
Abbreviations: BADS, Behavioral Assessment of the Dysexecutive Syndrome; DEX, Dysexecutive Questionnaire; rMSSD, root mean square successive difference; QoL-
profile, quality of life profile.
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illnesses (eg, depressions, anxiety), with seven out of nine 
individuals (78%) suffering from symptoms requiring 
first-line treatment (unpublished data using the CIRS-G 
instrument). Although causal relationships should not be 
inferred from the present data, the present results may well 
have clinical implications. HRV biofeedback interventions 
have been shown to improve symptoms in patients with 
major depression and anxiety disorders related to emotional 
and behavioral dysregulation.40
The present findings support the notion that judgments 
of patient’s QoL obtained from acquainted health care pro-
fessionals are a valuable and reasonably accurate source of 
information.8 Our findings further demonstrate that patients’ 
HRV is related to QoL ratings obtained from acquainted 
health care professionals. HRV was observed to be higher 
in patients that were rated as experiencing better QoL and 
demonstrated fewer dysexecutive symptoms. In contrast, we 
observed mostly weak associations between self-rated QoL 
and patients’ vmHRV, suggesting a nil relationship between 
both variables. Hence, by considering only patient ratings 
in the present sample, important health-related information 
on quality of care and QoL of the patient would have been 
missed.
As pointed out previously, the present sample is atypical 
for research studies investigating vmHRV and its relation-
ship to other constructs. We investigated a small clinical 
sample with a range of comorbidities requiring therapy and, 
therefore, compromising internal validity of the study. We 
cannot exclude that the observed deficits or relationships 
are independent of other causes (eg, head injury, dementia 
unrelated to alcoholism, liver diseases, etc). Importantly and 
although a large body of research discusses the psychologi-
cal correlates of vmHRV in healthy and clinical samples, 
many studies suffer from limited ecological validity due to 
restrictive inclusion and exclusion criteria. This study put 
previous findings into practice and investigated QoL as a 
previously reported correlate of QoL in a “naturalistic” set-
ting in a challenging small and highly comorbid sample. A 
range of measures have been applied to test for robustness 
of the results. First, data were qualitatively inspected and 
visualized to check for possible outliers. In this context, 
robustness of the reported linear relationships was checked 
and beta weight differences are reported. The reported 
patterns of relationships between vmHRV and all six QoL 
dimensions are consistent. That is, proxy ratings are posi-
tively and strongly related to vmHRV, whereas mostly weak 
or nil relationships are observed between self-ratings and 
vmHRV. In addition, vmHRV is strongly and consistently 
related to the proxy-reported occurrence of executive dys-
functions (DEX total score), whereas again, weak/nil rela-
tionships are observed between the self-reported executive 
dysfunctions and vmHRV. This pattern of relationships is 
reproduced when inspecting correlations between the three 
underlying DEX factors: cognition, behavior, and emo-
tion.32,41–43 Second, we provide bootstrapped 95% CIs and 
SEs for the computed central tendencies and correlations. 
Third, the present study maximizes the trait-component of 
baseline vmHRV measures by averaging over more than one 
assessment. This contributes to the stability and internal 
validity of the present findings.28 In the present study, no 
significant findings based on single measurements were 
found (unreported here).
To the best of our knowledge, the present study is the first 
to investigate direct relationships between emotion regulation 
capacity, the occurrence of everyday executive dysfunctions, 
and QoL in a sample of chronic patients with severe multi-
morbid conditions. The present preliminary results suggest 
that vmHRV demonstrates construct validity, given the 
relative stability of correlations investigated. While internal 
validity of the present study is limited, its external validity 
would seem to be adequate. More precisely, external validity 
is important as it demonstrates the applicability of the present 
research design and approach to a highly complex multimor-
bid clinical sample. We were able to perform accurate and 
repeated assessments of vmHRV in a complex clinical con-
text with a wide variety of intervening confounding factors. 
Thus, our paper contributes to the applicability of vmHRV 
by stressing the necessity of multiple measurements to 
ensure trait characteristics of HRV. Pending further research 
and replication in larger samples, HRV could be useful in 
situations where expert ratings are unclear (eg, disagreement 
within a team, high degree of staff fluctuation in transition 
periods). First studies on applying vmHRV assessments to 
clinical samples have been published.12
Conclusion
The present study demonstrates that individuals with ARBD 
have low to very low HRV scores compared to healthy adults 
and that patients’ HRV is related to QoL ratings obtained 
from acquainted health care professionals. We demonstrated 
the construct validity of vmHRV, given the relative stability 
of the investigated associations. We performed accurate and 
repeated assessments of vmHRV in a complex clinical context 
with many intervening factors. We thus see the contribution 
of this research in the fact that we put a well-known and as 
such well-established psychophysiological measure to the test 
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under challenging contextual situations in a natural  setting 
(low sample size, heterogeneous sample with multiple comor-
bidities, and intellectual impairment). Hence, we conclude 
that demonstrating the practical use of a tool and applicability 
of its measures in many diverse clinical settings is a crucial 
and necessary step for this promising method to slowly move 
from the laboratory to the clinical field.
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